Xtant Medical Holdings Stock Performance
| XTNT Stock | USD 0.89 0.02 2.20% |
The firm maintains a market beta of 1.99, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Xtant Medical will likely underperform. Xtant Medical Holdings has an expected return of -0.18%. Please make sure to check out Xtant Medical Holdings maximum drawdown, as well as the relationship between the daily balance of power and relative strength index , to decide if Xtant Medical Holdings performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Xtant Medical Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors. ...more
Last Split Factor 1:12 | Dividend Date 2018-02-14 | Last Split Date 2018-02-14 |
1 | GoodRx Holdings, Inc. Reports Next Week What Awaits | 02/22/2024 |
2 | Xtant Medical increases revolving credit facility to 17M | 03/07/2024 |
3 | Xtant Medical Holdings, Inc. Sees Large Decline in Short Interest - MarketBeat | 03/14/2024 |
4 | Earnings call Xtant Medical posts record Q4 revenue, eyes growth in 2024 | 04/01/2024 |
5 | Acquisition by Scott Neils of 177551 shares of Xtant Medical subject to Rule 16b-3 | 04/03/2024 |
6 | Acquisition by Sean Browne of 731632 shares of Xtant Medical subject to Rule 16b-3 | 04/05/2024 |
7 | Doctors beware Your credentials could land you in prison | 04/23/2024 |
| Begin Period Cash Flow | 20.5 M |
Xtant |
Xtant Medical Relative Risk vs. Return Landscape
If you would invest 108.00 in Xtant Medical Holdings on January 25, 2024 and sell it today you would lose (19.00) from holding Xtant Medical Holdings or give up 17.59% of portfolio value over 90 days. Xtant Medical Holdings is currently does not generate positive expected returns and assumes 5.0683% risk (volatility on return distribution) over the 90 days horizon. In different words, 44% of stocks are less volatile than Xtant, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Xtant Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Xtant Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Xtant Medical Holdings, and traders can use it to determine the average amount a Xtant Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0357
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | XTNT |
Estimated Market Risk
| 5.07 actual daily | 44 56% of assets are more volatile |
Expected Return
| -0.18 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Xtant Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Xtant Medical by adding Xtant Medical to a well-diversified portfolio.
Xtant Medical Fundamentals Growth
Xtant Stock prices reflect investors' perceptions of the future prospects and financial health of Xtant Medical, and Xtant Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Xtant Stock performance.
| Return On Equity | 0.0154 | ||||
| Return On Asset | -0.0831 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | (0.14) % | ||||
| Current Valuation | 136.21 M | ||||
| Shares Outstanding | 130.22 M | ||||
| Price To Earning | (0.41) X | ||||
| Price To Book | 2.12 X | ||||
| Price To Sales | 1.19 X | ||||
| Revenue | 91.3 M | ||||
| Gross Profit | 32.14 M | ||||
| EBITDA | (6.98 M) | ||||
| Net Income | 660 K | ||||
| Cash And Equivalents | 16.5 M | ||||
| Cash Per Share | 0.19 X | ||||
| Total Debt | 23.56 M | ||||
| Debt To Equity | 0.60 % | ||||
| Current Ratio | 3.57 X | ||||
| Book Value Per Share | 0.39 X | ||||
| Cash Flow From Operations | (9.52 M) | ||||
| Earnings Per Share | 0.01 X | ||||
| Market Capitalization | 117.78 M | ||||
| Total Asset | 92.61 M | ||||
| Retained Earnings | (243.01 M) | ||||
| Working Capital | 41.88 M | ||||
| Current Asset | 45.04 M | ||||
| Current Liabilities | 21.47 M | ||||
About Xtant Medical Performance
To evaluate Xtant Medical Holdings Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Xtant Medical generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Xtant Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Xtant Medical Holdings market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Xtant's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 375.68 | 382.25 | |
| Return On Tangible Assets | 0.01 | 0.01 | |
| Return On Capital Employed | (0.15) | (0.15) | |
| Return On Assets | 0.01 | 0.01 | |
| Return On Equity | 0.01 | 0.01 |
Things to note about Xtant Medical Holdings performance evaluation
Checking the ongoing alerts about Xtant Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Xtant Medical Holdings help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Xtant Medical generated a negative expected return over the last 90 days | |
| Xtant Medical has high historical volatility and very poor performance | |
| Xtant Medical has some characteristics of a very speculative penny stock | |
| Xtant Medical Holdings currently holds about 16.5 M in cash with (9.52 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.19. | |
| Xtant Medical has a poor financial position based on the latest SEC disclosures | |
| Roughly 69.0% of the company outstanding shares are owned by institutional investors | |
| Latest headline from kevinmd.com: Doctors beware Your credentials could land you in prison |
- Analyzing Xtant Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Xtant Medical's stock is overvalued or undervalued compared to its peers.
- Examining Xtant Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Xtant Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Xtant Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Xtant Medical's stock. These opinions can provide insight into Xtant Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Xtant Medical Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Complementary Tools for Xtant Stock analysis
When running Xtant Medical's price analysis, check to measure Xtant Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xtant Medical is operating at the current time. Most of Xtant Medical's value examination focuses on studying past and present price action to predict the probability of Xtant Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xtant Medical's price. Additionally, you may evaluate how the addition of Xtant Medical to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |
Is Xtant Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Xtant Medical. If investors know Xtant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Xtant Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.01 | Revenue Per Share 0.767 | Quarterly Revenue Growth 0.841 | Return On Assets (0.08) | Return On Equity 0.0154 |
The market value of Xtant Medical Holdings is measured differently than its book value, which is the value of Xtant that is recorded on the company's balance sheet. Investors also form their own opinion of Xtant Medical's value that differs from its market value or its book value, called intrinsic value, which is Xtant Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Xtant Medical's market value can be influenced by many factors that don't directly affect Xtant Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Xtant Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Xtant Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Xtant Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.